<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Immunology 2002 106 200&#226;&#8364;&#8220;211 <br />  <br />  <br />  <br />  <br />    Accumulation potent cd T-cell stimulator deletion lytB gene <br />                                Escherichia coli <br />  <br />  <br />    MATTHIAS EBERL,*&quot; BORAN ALTINCICEK,{&quot; ANN-KRISTIN KOLLAS,*&quot; SILKE SANDERBRAND,{ <br />     UTE BAHR,{ ARMIN REICHENBERG,{ EWALD BECK,* DONALD FOSTER,1 JOCHEN WIESNER,{ <br /> MARTIN HINTZ{ &amp; HASSAN JOMAA{ *Biochemisches Institut, Justus-Liebig-Universita&#194;&#168;t Giessen, Giessen, Germany, <br />  {Jomaa Pharmaka GmbH, Giessen, Germany, {Instrumentelle Analytische Chemie, Johann Wolfgang Goethe-Universita&#194;&#168;t <br />       Frankfurt Main, Frankfurt, Germany 1Department Cytokine Biology, Zymogenetics Inc., Seattle, <br />                                                Washington, USA <br />  <br />  <br />  <br />  <br />                                                             SUMMARY <br />                  Activation human Vc9/Vd2 T cells pathogens depends presence small <br />                  phosphorylated non-peptide compounds derived 2-C-methyl-D-erythritol <br />                  4-phosphate (MEP) pathway isoprenoid biosynthesis. We demonstrate in <br />                  Escherichia coli mutants deficient lytB, essential gene MEP pathway, potent <br />                  Vc9/Vd2 T-cell activator accumulates factor approximately 150 compared wild-type <br />                  E. coli. The compound responsible strong immunogenicity E. coli mutant was <br />                  subsequently characterized identified small pyrophosphorylated metabolite, a <br />                  molecular mass 262 Da, derived MEP pathway. Stimulation human peripheral <br />                  blood mononuclear cells (PBMC) extracts prepared lytB-deficient E. coli <br />                  mutant led upregulation T-cell activation markers surface Vc9/Vd2 T cells as <br />                  proliferation expansion Vc9/Vd2 T cells. This response dependent on <br />                  costimulatory growth factors, interleukin (IL)-2, IL-15 IL-21. Significant levels of <br />                  interferon-c (IFN-c) tumour necrosis factor-a (TNF-a) secreted presence of <br />                  IL-2 IL-15, presence IL-21, demonstrating proliferating <br />                  phosphoantigen-reactive Vc9/Vd2 T cells necessarily produce proinflammatory <br />                  cytokines. <br />  <br />  <br />  <br />  <br />                                                                                              INTRODUCTION <br />                                                                           cd T cells play crucial role immune response <br />    Received 29 October 2001; revised 16 January 2002; accepted            microbial pathogens, capable of <br /> 11 February 2002. <br />                                                                           establishing chronic debilitating diseases, as <br />    Abbreviations: DOXP, 1-deoxy-D-xylulose 5-phosphate; Dxr,              tuberculosis malaria.1,2 In humans, activation Vc9/ <br /> 1-deoxy-D-xylulose 5-phosphate reductoisomerase; ESI, electro-            Vd2 T cells pathogenic micro-organisms depends <br /> spray ionization; FBPP, 3-formyl-1-butyl pyrophosphate; <br />                                                                           compounds derived 2-C-methyl-D-erythritol <br /> HMB-PP, (E )-4-hydroxy-3-methyl-but-2-enyl pyrophosphate; <br /> IFN-c, interferon-c; IL, interleukin; IPP, isopentenyl pyrophos- <br />                                                                           4-phosphate (MEP)1 pathway isoprenoid biosynthesis.3,4 <br /> phate; LMW, low molecular weight; ME, 2-C-methyl-D-erythritol;            Beside chloroplasts algae higher plants, <br /> MEcPP, 2-C-methyl-D-erythritol 2,4-cyclopyrophosphate; MEP,               pathway utilized bacteria,5,6 as <br /> 2-C-methyl-D-erythritol 4-phosphate; MS, mass spectrometry;               apicomplexan protozoa Plasmodium falciparum,7 <br /> TNF-a, tumour necrosis factor-a.                                          apparently absent vertebrates.8&#226;&#8364;&#8220;11 Thus, the <br />     &quot;M. Eberl, B. Altincicek A.-K. Kollas contributed equally         unconventional cd T-cell reactivity common metabolites <br /> <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> work.                                                             ensures quick efficient immune response a <br />                                                                           broad range evolutionarily distant pathogens that <br />     Correspondence: Dr M. Eberl, Biochemisches Institut, <br /> Klinikum der Justus-Liebig-Universita&#194;&#168;t Giessen, Friedrichstrasse         escape classical major histocompatibility <br /> 24, D-35392 Giessen, Germany. E-mail: matthias.eberl@biochemie.           complex-restricted mechanisms.12 While isopentenyl pyro- <br /> med.uni-giessen.de                                                        phosphate (IPP), precursor isoprenoids, the <br />  <br />  <br />                                                                     200                                  #   2002 Blackwell Science Ltd <br />                                      A potent cd T-cell activator DlytB E. coli                                     201 <br />  <br />  <br /> first ligand described Vc9/Vd2 T-cell receptor          isomerase (D-glyceraldehyde-3-phosphate-ketol-isomerase; <br /> (TCR),13&#226;&#8364;&#8220;15 natural amounts IPP bacteria           Sigma) 40 mg recombinant E. coli DOXP synthase.24 <br /> not reach minimum required inducing T-cell              [2-14C]DOXP precipitated 100 mM BaCl2 and <br /> activation.3 Fournie&#194;&#180; co-workers showed              80% ethanol, subsequently transformed into <br /> mycobacterial molecule likely 3-formyl-1-butyl            [2-14C]MEP presence 25 mM NADPH (Sigma) <br /> pyrophosphate (FBPP) approximately 1000-fold            using 300 mg recombinant E. coli DOXP reducto- <br /> active IPP;16,17 structural similarity   isomerase (Dxr).7 Samples passed porous <br /> IPP, FBPP suggested intermediate MEP        graphitized carbon column (Hypercarb; Thermo Hypersil, <br /> pathway.17 However, terminal steps MEP               Runcorn, UK). Finally, [2-14C]MEP purified a <br /> pathway remain elucidated, 2-C-methyl-D-       MonoQ column (Amersham Pharmacia, Freiburg, <br /> erythritol 2,4-cyclopyrophosphate (MEcPP)        Germany), using 20 mM Tris&#226;&#8364;&#8220;HCl, pH 8.0, rising <br /> metabolite reaction sequence known far,           concentrations NaCl, Gynkotech HPLC device <br /> evidence FBPP natural intermediate IPP             (Gynkotech, Germering, Germany). This procedure <br /> biosynthesis missing.18                                      yielded &lt;1.6 mg [2-14C]MEP activity of <br />      Most recently, role genes dxr, gcpE lytB     &lt;344 MBq/mmol (data shown). <br /> in MEP pathway demonstrated and <br /> others.19&#226;&#8364;&#8220;23 We constructed Escherichia coli mutant strains <br />                                                                 Metabolic 14C labelling metabolites derived <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> utilizing exogenously provided mevalonate producing <br />                                                                 MEP pathway <br /> IPP, owing complementation plasmid that <br />                                                                 A fresh overnight culture DgcpE DlytB mutants, <br /> provides yeast enzymes classical mevalonate <br />                                                                 respectively, diluted 1 : 100 2 ml medium sup- <br /> pathway isoprenoid synthesis. Consequently, mutants <br />                                                                 plemented 100 mM mevalonate 100 mg/ml <br /> deficient genes dxr, gcpE lytB, respectively, are <br />                                                                 ampicillin. As MEP taken E. coli, <br /> viable culture medium supplemented with <br />                                                                 [2-14C]MEP treated 2 U shrimp alkaline phos- <br /> mevalonate.20,21 Low-molecular-weight (LMW) extracts <br />                                                                 phatase (Roche Diagnostics, Mannheim, Germany) 37u <br /> prepared Ddxr DgcpE mutants signifi- <br />                                                                 30 min, resulting product, [2-14C]-methyl-D- <br /> cantly reduced capacity stimulate Vc9/Vd2 T cells, <br />                                                                 erythritol ([2-14C]ME), added cultures a <br /> compared parent E. coli strain,4 proving the <br />                                                                 concentration 50 mM (corresponding c. 17.1 kBq/ml). <br /> importance MEP pathway biosynthesis the <br />                                                                 Fosmidomycin, potent inhibitor Dxr enzyme,7 was <br /> cd T-cell activator. In striking contrast, that <br />                                                                 used 100 mM block endogenous biosynthesis of <br /> in DlytB bacteria, Vc9/Vd2 T cell-stimulating molecule <br />                                                                 MEP consequently ensure optimum incorpora- <br /> is greatly accumulated. <br />                                                                 tion [2-14C]ME metabolites produced MEP <br />                                                                 pathway. After incubation 37u 6 hr, bacterial cells <br />                                                                 pelleted, resuspended 200 ml 5 mM Tris&#226;&#8364;&#8220;HCl, <br />               MATERIALS AND METHODS                             pH 7.5, lysed repeated freeze&#226;&#8364;&#8220;thaw cycles the <br /> Bacteria plasmids                                           presence 2 mg lysozyme (Merck). Cell debris was <br /> Bacterial strains E. coli DgcpE E. coli DlytB          pelleted supernatants loaded Microcon <br /> precise in-frame deletions gcpE lytB, respectively,      YM-3 filters (Millipore, Eschborn, Germany). The flow- <br /> were derived wild-type E. coli K-12 strain, DSM        lyophilized, resuspended 3 ml H2O <br /> no. 498, ATCC 23716.20,21 All mutant wild-type (WT)         analysed high performance layer chromato- <br /> strains harboured plasmid pSC-MVA synthetic              graphy silica gel plates (Kieselgel 60; Merck) developed with <br /> operon express Saccharomyces cerevisiae ERG12                propanol : ethylacetate : H2O (6 : 1 : 3). Radioactive spots <br /> (mevalonate kinase), ERG8 (phosphomevalonate kinase)            visualized autoradiography exposure for <br />                                                                 4 weeks. <br /> and ERG19 (mevalonate pyrophosphate decarboxylase).20 <br /> Bacteria grown Standard 1 medium (Merck, <br /> Darmstadt, Germany) presence 150 mg/ml                cd T-cell stimulation assays <br /> ampicillin (Sigma, Taufkirchen, Germany) 200 mM             Bacteria harvested fresh liquid cultures an <br /> mevalonate; stock solution 1 M mevalonate              OD600 &lt;0.8 sonicated 1 : 10 volume of <br /> prepared hydrolysing mevalonolactone (Fluka,                 phosphate-buffered saline (PBS). LMW fractions were <br /> Taufkirchen, Germany) 1 M KOH 37u 30 min.           obtained using Centriprep 3-kDa filters (Millipore). <br />                                                                 Blood samples healthy donors kindly <br /> Synthesis 14C-labelled MEP                                   provided Institut fu&#194;&#168;r Klinische Immunologie <br /> For enzymatic synthesis [2-14C]1-deoxy-D-xylulose            und Transfusionsmedizin (Klinikum der Justus-Liebig- <br /> 5-phosphate (DOXP), 0.8 mg pyruvate (Sigma), 1.4 mg          Universita&#194;&#168;t Giessen, Giessen, Germany). Peripheral blood <br /> of [2-14C]pyruvate (585 MBq/mmol; NEN Life Science              mononuclear cells (PBMC) isolated heparinized <br /> Products, Zaventem, Belgium) 5.5 mg D-fructose-          peripheral blood density centrifugation LSM <br /> 1,6-bisphosphate (Sigma) incubated 0.44 U rabbit      medium (ICN Biomedicals, Eschwege, Germany). PBMC <br /> aldolase     (D-fructose-1,6-bisphosphate-D-glyceraldehyde-     (2r105/well) seeded RPMI-1640 (200 ml) supple- <br /> 3-phosphate-lyase; Sigma), 22.4 U rabbit triose phosphate       mented 25 mM HEPES, 2 mM L-glutamine, 25 mg/ml <br />  <br />  <br /> #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />  202                                                 M. Eberl et al. <br />  <br />  <br /> gentamycin (all Life Technologies, Karlsruhe,            DgcpE #20, analysed electrospray ionization <br /> Germany) 10% human AB serum (Bayerisches Rotes            orthogonal-time-of-flight mass spectrometry (ESI-o-ToF <br /> Kreuz, Augsburg, Germany). For routine assays, recombi-       MS) (Mariner; PE Biosystems, Framingham, MA) <br /> nant human interleukin-2 (IL-2) (Life Technologies)       equipped nano-ESI-source (Protana, Odense, <br /> used 10 U/ml short-term cultures (18&#226;&#8364;&#8220;72 hr),       Denmark). Sample solutions (3 ml) filled gold- <br /> at 100 U/ml longer culture periods. For comparison        coated nanospray capillaries sprayed flow rates of <br /> between different growth factors, IL-2, IL-15 (both           10&#226;&#8364;&#8220;30 nl/min. The voltage nanospray needle set <br /> Promocell, Heidelberg, Germany), IL-2125 added         900 V; temperature heated transfer capillary <br /> at concentration 0.1&#226;&#8364;&#8220;10 ng/ml. LMW preparations          200uC. Spectra taken negative ion mode <br /> were added dilutions 1 200 (corresponding         averaged 10 scans 3 seconds each. Structural <br /> &lt;1.0r107 bacteria/well) 1 5r106 (&lt;400 bacteria/well).   analysis MS-MS selected ions performed <br /> Cells incubated medium alone, cells stimulated         using quadruple ion trap MS (LCQ; Finnigan MAT, <br /> with 10 mM IPP (Sigma), served negative positive       San Jose, CA) relative collision energy 20&#226;&#8364;&#8220;30%. <br /> controls, repectively. Cells harvested different <br /> time-points analysed cd T-cell activation cd      Statistical analysis <br /> T-cell outgrowth Epics XL flow cytometer sup-           Data expressed mean valuetstandard error of <br /> ported Expo32 software (Beckman Coulter, Krefeld,        mean (SEM). Statistical analysis performed using <br /> Germany), using following Beckman Coulter                 two-tailed Student&#226;&#8364;&#8482;s t-test unequal variance, with <br /> monoclonal antibodies (mAbs): CD3-PC5 (UCHT1),                differences considered statistically significant P-value <br /> Vc9-fluorescein isothiocyanate (FITC) (Immu360), Vd2-         &lt;0.05. R2 values calculated using Microsoft Excel <br /> FITC (Immu389), CD25-phycoerythrin (PE) (B1.49.9),            2000 software. <br /> CD69-PE (TP1.55.3), CD94-PE (HP-3B1), HLA-DR- <br /> PE (Immu357), appropriate isotype                                      RESULTS <br /> controls. Gates set total lymphocytes on <br />                                                               E. coli DlytB mutants accumulate metabolite that <br /> CD3+ lymphocytes, results obtained 10 30 000 <br />                                                               derived methyl-D-erythritol <br /> gated events expressed percentage Vc9+ cells <br /> among CD3+ lymphocytes day 6, CD69+ (day 1),        In recent studies, demonstrated enzymes <br /> CD25+ (day 3), CD94+ (day 6), HLA-DR+ (day 6) cells        encoded E. coli genes gcpE lytB essential <br /> among Vc9+ CD3+ lymphocytes. For cytokine analysis,           isoprenoid synthesis MEP pathway.20,21 As <br /> culture supernatants taken 18 72 hr,           final biochemical steps pathway remain to <br /> and tested tumour necrosis factor-a (TNF-a)           unveiled, labelling experiments performed order <br /> interferon-c (IFN-c), respectively, using human OptEIA    gain detailed insight function LytB <br /> sets (Becton-Dickinson, Hamburg, Germany).                    GcpE proteins. Thus, DlytB DgcpE mutants were <br />                                                               grown medium supplemented 14C-labelled ME. <br /> Chromatography mass spectrometry                          Separation corresponding LMW extracts thin- <br /> Cultures DgcpE DlytB mutants, respectively,       layer chromatography revealed DgcpE mutants, <br /> grown 100 ml Standard 1 medium OD600           [2-14C]ME metabolized (Fig. 1). In <br /> &lt;0.8. LMW extracts prepared described           contrast, DlytB mutant additional <br /> (except 20 mM ammonium formiate, pH 8.0, used        spot indicating accumulation unknown metabolite <br /> instead PBS) passed Isolute C18 reverse-       reduced chromatographic mobility. Unfortunately, the <br /> phase (RP) column (International Sorbent Technology,          amounts labelled material limited allow quan- <br /> Mid Glamorgan, UK). The flow-through loaded          tification radioactivity liquid scintillation further <br /> onto Source 15Q anion-exchange column (Amersham             characterization mass spectrometry (data shown). <br /> Pharmacia) fractionated using Waters HPLC device <br /> coupled PDA 996 photodiode array detector (Waters, <br />                                                               Disruption lytB gene leads &gt;100-fold <br /> Eschborn, Germany), scanning 1 spectrum/second between <br />                                                               accumulation cd T-cell stimulating molecule <br /> l210 500 nm 1.2-nm resolution. Buffers used <br /> were: A, 20 mM ammonium formiate, pH 8.0; B, 500 mM           From previous work know compound derived <br /> ammonium formiate, pH 8.0; C, 1 M ammonium formiate;          MEP pathway represents natural activator <br /> and chromatography performed flow rate          phosphoantigen-reactive human cd T cells.3,4 Thus, we <br /> 10 ml/min follows: wash, 30 min 100% A; elution, linear    speculated metabolite accumulating DlytB <br /> gradient 100% A 100% B 30 min; 10 min 100% C;      bacteria (Fig. 1) fact highly immunogenic <br /> equilibration, 10 min 100% A. Fractions collected        substance. Here, cd T-cell stimulation assays, LMW <br /> first tested standard cd T-cell activation assays     extracts prepared WT bacteria induced expansion of <br /> dilution 1 400 000, using pools consisting      Vc9/Vd2 T cells dilutions 1 : 12 500, correspond- <br /> fractions each. The individual fractions pool   ing 1.6r105 bacteria/well (Fig. 2); accordance with <br /> inducing upregulation CD69 expression 18 hr         previous observations,4 LMW extracts DgcpE <br /> were tested dilution 1 400 000. The active    mutants active WT E. coli. <br /> sample, DlytB #20, corresponding negative control,    However, striking contrast, DlytB mutants exhibited <br />  <br />  <br />                                                                       #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />                                       A potent cd T-cell activator DlytB E. coli                                                                                             203 <br />  <br />                                                                                          (a) <br />                                                                                                                    80 <br />  <br />  <br />  <br />  <br />                                                                                       Vc9+ [% CD3+ lymphocytes] <br />                                                                                                                    60 <br />  <br />  <br />                                                                                                                    40 <br />  <br />  <br />                                                                                                                    20 <br />               ME <br />  <br />                                                                                                                     0 <br />                                                                                                                    1E+06          1E+05                1E +04        1E +03 <br />                                                                                                                                        Dilution factor <br />  <br />  <br />  <br />                                                                       (b) <br />                                                                                 103                                                                  103 <br />  <br />                                                                                 102                                             2.1%                 102                  10.1% <br />  <br />  <br />  <br />  <br />                                                                       CD3-PC5 <br />  <br />  <br />  <br />  <br />                                                                                                                                            CD3-PC5 <br />                                                                                 101                                                                  101 <br />  <br />                                                                                 100                                                                  100 <br />  <br />                                DgcpE     DlytB <br />                                                                                                                   100     101    102   103                  100      101   102    103 <br /> Figure 1. (a) Thin-layer chromatography analysis Escherichia                                                         Vc9-FITC                                  Vc9-FITC <br /> coli DgcpE DlytB grown presence [2-14C]2-C-methyl-D-              103                                                                  103 <br /> erythritol (ME). Low molecular weight preparations examined <br /> on HPTLC silica gel plate, radioactive spots visualized             102                                             2.6%                 102                 55.8% <br /> by autoradiography. <br />                                                                       CD3-PC5 <br />  <br />  <br />  <br />  <br />                                                                                                                                            CD3-PC5 <br />                                                                                 101                                                                  101 <br />  <br />  <br /> a cd T-cell activity considerably                    100                                                                  100 <br /> WT bacteria; significant outgrowth Vc9/Vd2 T cells <br /> could detected dilutions 1 : 312 500, cor-                                                          100     101    102   103                  100      101   102    103 <br /> responding 6.4r103 bacteria/well. The relative increase                                                              Vc9-FITC                                  Vc9-FITC <br /> in cd T cells detected did reflect true expansion this <br /> population, substantial death ab T cells occurred            Figure 2. Disruption lytB gene increases cd T-cell <br /> (data shown), accordance similar                 stimulatory potential Escherichia coli. (a) Vc9+ T-cell outgrowth <br /> observations groups.2,17,26&#226;&#8364;&#8220;29                             presence bacterial extracts. Peripheral blood mononuclear <br />                                                                       cells (PBMC) incubated period 6 days medium <br />     We investigated LMW extracts <br />                                                                       alone, low molecular weight extracts prepared from <br /> prepared DlytB bacteria, measuring immunological              wild-type E. coli (black triangles), DgcpE (open circles), and <br /> parameters correlated cd T-cell activation phospho-           DlytB (open squares), different dilutions. Data shown represent <br /> antigens. Thus, dilution 1 : 62 500, DlytB extract        mean values+standard error mean donors <br /> did stimulate proliferation cd T cells,          analysed. (b) Flow cytometry analysis. PBMC incubated with <br /> induced upregulation activation markers CD25,                  medium (top left panel), LMW extracts prepared <br /> CD69 HLA-DR, C-type lectin CD94                    WT E. coli (top right panel), DgcpE (bottom left panel), or <br /> surface Vc9/Vd2 T cells, secretion TNF-a             DlytB (bottom right panel), dilution 1 : 12 500. Panels shown <br />                                                                       representative data obtained blood donor. <br /> and IFN-c PMBC (Fig. 3). This activity present <br /> in extracts WT DgcpE bacteria tested same <br /> dilution.                                                             mutant significantly lower, equivalent &lt;0.8 mM. <br />     Using serial dilutions IPP standard, obtained            Strikingly, LMW extracts bacteria deficient lytB <br /> positive correlations antigen concentration               greater 100-fold active extracts from <br /> cd T-cell activation, measured cd T-cell expansion                 WT bacteria, containing antigenic compound that <br /> and expression CD25 CD69 (Fig. 4). These calibra-              potent &lt;450 mM IPP. <br /> tion curves enabled estimate activity the <br /> bacterial extracts tested express IPP equivalents; <br />                                                                       The cd T-cell stimulating molecule purified by <br /> importantly, analyses performed gave similar <br />                                                                       anion-exchange chromatography <br /> levels (Table 1). Thus, LMW extracts WT E. coli had <br /> a cd T-cell stimulatory potential comparable IPP                In order characterize immunogenic molecule <br /> concentration &lt;3 mM, activity DgcpE             accumulating DlytB mutants, 3-kDa LMW filtrate <br />  <br />  <br /> #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />  204                                                                                   M. Eberl et al. <br />  <br />                                                                        CD25                                                                             CD69 <br />  <br />  <br />  <br />  <br />                                                                                                 CD69+ (% Vc9+ CD3+ lymphocytes) <br />                    CD25+ (% Vc9+ CD3+ lymphocytes) <br />                                                      100                                                                            100 <br />  <br />                                                      80                                                                             80 <br />  <br />                                                      60                                                                             60 <br />  <br />                                                      40                                                                             40 <br />  <br />                                                      20                                                                             20 <br />  <br />                                                       0                                                                              0 <br />                                                            med   IPP    wt     gcpE   lytB                                                med    IPP      wt     gcpE   lytB <br />  <br />  <br />  <br />  <br />                                                                        CD94                                                                             HLA-DR <br />  <br />  <br />  <br />  <br />                                                                                                 HLA-DR+ (% Vc9+ CD3+ lymphocytes) <br />                    CD94+ (% Vc9+ CD3+ lymphocytes) <br />  <br />  <br />  <br />  <br />                                                      100                                                                            100 <br />  <br />                                                      80                                                                             80 <br />  <br />                                                      60                                                                             60 <br />  <br />                                                      40                                                                             40 <br />  <br />                                                      20                                                                             20 <br />  <br />                                                       0                                                                              0 <br />                                                            med   IPP    wt     gcpE   lytB                                                 med    IPP     wt     gcpE   lytB <br />  <br />  <br />  <br />  <br />                                                                        TNF-a                                                                             IFN-c <br />                                                      100                                                                            500 <br />  <br />                                                      80                                                                             400 <br />                          TNF-a (pg/ml) <br />  <br />  <br />  <br />  <br />                                                                                                        IFN-c (pg/ml) <br />  <br />  <br />  <br />  <br />                                                      60                                                                             300 <br />  <br />                                                      40                                                                             200 <br />  <br />                                                      20                                                                             100 <br />  <br />                                                       0                                                                              0 <br />                                                            med   IPP    wt     gcpE   lytB                                                 med    IPP     wt     gcpE   lytB <br />  <br />       Figure 3. Effect DlytB low molecular weight extract range immunological parameters. Peripheral blood <br />       mononuclear cells (PBMC) incubated medium alone, isopentenyl pyrophosphate (IPP) 2 mM, LMW <br />       extract prepared wild-type (WT) Escherichia coli, DgcpE, DlytB, dilution 1 : 62 500. Data represent results from <br />       donor, expression CD25 (day 3), CD69 (day 1), CD94 (day 6) human leucocyte antigen (HLA)-DR (day 6) on <br />       Vc9+ T cells, secretion tumour necrosis factor (TNF-a) (day 1) interferon-c (IFN-c) (day 3) PBMC. Note: the <br />       <span id='am-3' about='xsp:pattern' typeof='owl:Thing'>pattern</span> shown typical number blood donors analysed (n=3&#226;&#8364;&#8220;6); however, absolute levels CD94 HLA-DR <br />       expression, absolute amounts cytokines secreted, greater biological variation individuals than <br />       data cd T-cell expansion expression CD25 CD69. Also, donors changes CD94 HLA-DR <br />       expression presence serial dilutions phosphoantigens inconsistent despite good dose-dependent responses, as <br />       judged CD25 CD69 expression, making CD25 CD69 reproducible activation markers tested. <br />  <br /> was passed C18 reversed-phase column                                                pools cd T-cell reactivity. No sample obtained from <br /> fractionated subsequently anion-exchange chromato-                                          DgcpE bacteria stimulated cd T cells background <br /> graphy, using ammonium formiate eluent. An LMW                                              levels. In contrast, peak bioactivity recovered the <br /> preparation DgcpE bacteria subjected                                           pool consisting fractions 19&#226;&#8364;&#8220;22, samples <br /> same protocol served control. Unexpectedly,                                     collected, flow-through column and <br /> was significant difference absorbance profiles                                       wash fractions, remained negative (Fig. 5). Testing the <br /> between DgcpE DlytB mutants, measured                                                  individual fractions positive pool showed the <br /> between 210 500 nm (Fig. 5, data shown).                                           cd T-cell-stimulating molecule eluted fraction no. 20, <br /> Consequently, fractions collected tested                                      ammonium formiate concentration &lt;250 mM. <br />  <br />  <br />                                                                                                                                       #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />                                                A potent cd T-cell activator DlytB E. coli                                          205 <br />  <br />                   10.0                                                 Table 1. Immunological activity extracts different strains <br />                                                                                             Escherichia coli&quot; <br />  <br />                                                                        Equivalent to <br />                    1.0                            R2 =0.997801         IPP (mM)               WT              DgcpE               DlytB <br />        IPP (&#194;&#181;M) <br />  <br />  <br />  <br />  <br />                                                                        Expt. 1{           4.04             0.69             462.58 <br />                                                                        Expt. 2{           2.54             0.85             475.11 <br />                    0.1 <br />                                                                        Expt. 31           2.66             0.79             394.64 <br />                                                                        MeantSEM           3.08t0.48        0.78t0.05*       444.11t25.00* <br />  <br />                    0.0                                                    &quot;Calibration curves obtained using serial dilutions an <br />                          0     20      40      60      80        100   isopentenyl pyrophosphate (IPP) standard (Fig. 4). Bioactivity the <br />                                 Vc9+ (% CD3+ lymphocytes)              bacterial extracts analysed expressed IPP equivalents three <br />                                                                        experiments performed. <br />                                                                           {Outgrowth Vc9+ CD3+ T cells, day 6 (n=3). <br />                   10.0                                                    {Upregulation CD25 Vc9+ CD3+ T cells, day 3 (n=3). <br />                                                                           1Upregulation CD69 Vc9+ CD3+ T cells, day 1 (n=3). <br />                                                                           *P&lt;0.05, using two-tailed Student&#226;&#8364;&#8482;s t-test unequal variance. <br />                                                                           SEM, standard error mean; WT, wild type. <br />  <br />                    1.0 <br />        IPP (&#194;&#181;M) <br />  <br />  <br />  <br />  <br />                                                 R2 =0.944496           derived DlytB bacteria, DlytB #20, cor- <br />                                                                        responding fraction DgcpE mutants, DgcpE #20. In <br />                    0.1                                                 negative ion spectrum DlytB #20, abundant <br />                                                                        peak m/z 261 [M-H]x; peaks m/z 381 <br />                                                                        [M+NaHPO4]x m/z 523 [2M-H]x correlated <br />                                                                        molecule (Fig. 6). These signals detectable <br />                    0.0                                                 fraction DgcpE #20, prominent peak <br />                          0     20      40     60       80        100 <br />                                                                        m/z 277, common impurity peaks (e.g. m/z 216.9 <br />                              CD25+ (% Vc9+ CD3+ lymphocytes) <br />                                                                        m/z 1192.2) comparable intensities fraction <br />                                                                        DlytB #20; residual UV absorbance fractions <br />                   10.0                                                 DlytB #20 DgcpE #20 ascribed ion at <br />                                                                        m/z 1192.2 (data shown). Negative mode ion trap <br />                                R2 =0.998545                            MS/MS m/z 261 yielded ions m/z 243 (correspond- <br />                    1.0                                                 ing H2O loss) m/z 159 (corresponding pyro- <br />                                                                        phosphate anion, HP2Ox    6 ) (data shown). Subsequent <br />        IPP (&#194;&#181;M) <br />  <br />  <br />  <br />  <br />                                                                        large-scale purification cd T-cell activator a <br />                                                                        1-l culture E. coli DlytB mutants anion-exchange <br />                    0.1 <br />                                                                        chromatography, structural characterization by <br />                                                                        1 <br />                                                                          H, 13C 31P nuclear magnetic resonance spectros- <br />                                                                        copy nuclear Overhauser effect spectroscopy anal- <br />                    0.0                                                 ysis, (E )-4-hydroxy-3-methyl-but-2-enyl pyrophosphate <br />                          0     20      40     60       80        100 <br />                                                                        (HMB-PP) described elsewhere.30 <br />                              CD69+ (% Vc9+ CD3+ lymphocytes) <br />  <br /> Figure 4. Dose&#226;&#8364;&#8220;response isopentenyl pyrophosphate (IPP). <br /> Peripheral blood mononuclear cells incubated medium          DlytB #20-driven cd T-cell activation does result <br /> alone, IPP different concentrations. The data represent     secretion proinflammatory cytokines the <br /> the mean valuetSEM donors analysed, Vc9+ T-cell         presence IL-21 <br /> outgrowth, expression CD25 CD69 Vc9+ T cells. <br /> Trend lines R2 values calculated using Microsoft Excel        Apart reactivity small pyrophosphory- <br /> software.                                                              lated molecules, Vc9/Vd2 T cells depend cytokines in <br />                                                                        local microenvironment, fact bias read- <br /> Titration fraction no. 20 IPP standard gave              outs bioactivity assays. Consequently, investigated <br /> a bioactivity corresponding &lt;2500 mM IPP (Table 2);                 influence different interleukins cd T-cell <br /> the fraction no. 21 &lt;500 mM IPP bioactivity             response novel activator present fraction <br /> (data shown).                                                      DlytB #20. IL-2 IL-15 clearly impor- <br />                                                                        tant growth factors known cd T cells, which <br />                                                                        synergize IL-12.26 IL-21 novel cytokine is <br /> Mass spectrometry analysis identifies molecule Mr 262 <br />                                                                        closely related IL-2 IL-15, produced activated <br /> To obtain structural information bioactive metabo-              CD4+ T cells CD19+ B cells CD14+ <br /> lite, ESI-MS analysis performed active fraction             monocytes.25 Here, cytokines, IL-2, IL-15 and <br />  <br />  <br /> #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />  206                                                                                 M. Eberl et al. <br />  <br />                                                                                                                                   80 <br />  <br />  <br />  <br />  <br />                                                                                               CD69+ (% Vd2+ CD3+ lymphocytes) <br />                                                                                                                                                                                                          anion exchange column <br />  <br />                                                                                                                                   60 <br />  <br />  <br />                                                                                                                                   40 <br />  <br />  <br />                                                                                                                                   20 <br />  <br />  <br />                              0.8                                                                                                   0 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                        11-14 <br />  <br />                                                                                                                                                                                                                                     15-18 <br />  <br />                                                                                                                                                                                                                                                  19-22 <br />  <br />                                                                                                                                                                                                                                                               23-26 <br />  <br />                                                                                                                                                                                                                                                                            27-30 <br />  <br />                                                                                                                                                                                                                                                                                    31-35 <br />                                                                                                                                                                                                          wash <br />                                                                                                                                        medium <br />  <br />                                                                                                                                                  IPP <br />  <br />                                                                                                                                                        LMW <br />  <br />  <br />  <br />                                                                                                                                                                                                f/t <br />                                                                                                                                                              RP <br />                              0.6 <br />  <br />  <br />  <br />  <br />                                                                                                                                                              CD69+ (% Vd2+ CD3+ lymphocytes) <br />                                                                                                                                                                                                 80 <br />     Absorbance 280 nm <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                 60 <br />                              0.4 <br />                                                                                                                                                                                                 40 <br />  <br />  <br />                                                                                                                                                                                                 20 <br />  <br />                              0.2                                                                                                                                                                     0 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                19 <br />  <br />                                                                                                                                                                                                                                             20 <br />  <br />                                                                                                                                                                                                                                                          21 <br />  <br />                                                                                                                                                                                                                                                                       22 <br />                                                                                                                                                                                                                 wash <br />                                0 <br />                                                                           19 <br />                                                                                20 <br />                                                                                     21 <br />                                                                                          22 <br />  <br />  <br />  <br />  <br />                            Figure 5. Fractionation bacterial extracts anion-exchange chromatography. DgcpE DlytB low molecular weight <br />                            (LMW) extracts, respectively, passed reverse phase (RP) column fractionated Source 15Q column, using <br />                            ammonium formiate gradient (20&#226;&#8364;&#8220;500 mM). Absorbance 280 nm shown solid line DlytB dashed line for <br />                            DgcpE. Fractions collected tested pools consisting each; fractions 19 22 subsequently tested <br />                            individually ability upregulate CD69 expression Vd2+ T cells. Samples tested were: medium control; isopentenyl <br />                            pyrophosphate (IPP) positive control, 10 mM; 3-kDa LMW filtrate, 1 50 000 (LMW) extract; LMW extract RP <br />                            column chromatography (=sample loaded Source 15Q column), 1 50 000 (RP); Source 15Q flow-through, 1 50 000 <br />                            (f/t); Source 15Q wash fraction, 1 50 000; fractions 11&#226;&#8364;&#8220;35, pools individually, 1 400 000. Solid bars, DgcpE; hatched <br />                            bars, DlytB. <br />  <br />  <br />  <br /> IL-21, costimulated expansion Vc9/Vd2 T cells                                                                            maximum IL-21 induced IFN-c levels lower <br /> among CD3+ T cells presence fraction DlytB #20,                                                                       achieved presence IL-2 IL-15. <br /> while antigen cytokines significant <br /> proliferative effect (Fig. 7). Moreover, IL-21 increased the <br /> DlytB #20-driven upregulation CD25 CD69 Vc9/                                                                                                                                    DISCUSSION <br /> Vd2 T cells, similarly IL-2 IL-15, effect                                                                    Over past years, Vc9/Vd2 T cells shown to <br /> on CD25 CD69 expression absence antigenic                                                                         react pathogenic bacteria, Brucella, <br /> stimulation barely detectable, contrast                                                                     Coxiella, Ehrlichia, E. coli, Francisella, Legionella, Listeria, <br /> cytokines tested. Addition IL-21 PBMC cultures                                                                            Mycobacterium, Pseudomonas, Salmonella Yersinia, as <br /> enhanced IL-2- IL-15-induced upregulation CD69                                                                        protozoan parasites Plasmodium and <br /> expression, presence absence antigenic                                                                        Toxoplasma.12,31,32 Although bacteria lacking the <br /> stimulation; additive effect CD25 expression cd                                                                      alternative MEP pathway isoprenoid synthesis, such <br /> T-cell proliferation pronounced (data shown).                                                                      Staphylococcus Streptococcus, capable of <br /> While IL-2 IL-15 costimulated DlytB #20-induced                                                                         stimulating Vc9/Vd2 T cells superantigen recognition <br /> synthesis TNF-a IFN-c PBMC, IL-21 did                                                                            sites,33,34 recent studies established general link <br /> not enhance DlytB #20-driven TNF-a production,                                                                              Vc9/Vd2 T-cell reactivity35 presence the <br />  <br />  <br />                                                                                                                                         #       2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />                                                     A potent cd T-cell activator DlytB E. coli                                                                                  207 <br />  <br />  <br /> MEP pathway.3,4 Accordingly, current data                                                                   HLA-DR,36 killer inhibitory receptor, <br /> now clear LytB enzyme21 plays crucial role                                                               CD94,37 surface Vc9/Vd2 T cells, proliferation <br /> metabolism natural Vc9/Vd2 TCR ligand. Stimula-                                                                     expansion Vc9/Vd2 T cells,4 secretion of <br /> tion human PBMC minute quantities DlytB                                                                         proinflammatory cytokines IFN-c TNF-a.27,38,39 <br /> LMW preparations led drastic upregulation                                                                          Recently, molecule Mr 262 (TUBag1) identified <br /> known T-cell activation markers CD25,26 CD6926                                                                         Mycobacterium fortuitum. Data ion-trap ESI-MS <br />                                                                                                                            comparative photodiode array absorption analysis <br />                                                                                                                            TUBag1, NMR spectroscopy signals that <br />       Table 2. Immunological activity fraction DlytB #20*                                                               obtained using corresponding c-UTP c-TTP <br />                                                                                                                            phosphodiesters, TUBag3 TUBag4, suggested that <br />                                  CD69 expression                                Bioactivity <br /> Dilution factor                 (% Vc9+ CD3+){                                  (mM IPP){ <br />                                                                                                                            mycobacterial cd T-cell activator FBPP.13,16,17 As <br />                                                                                                                            potent natural Vc9/Vd2 T-cell stimulator <br /> Medium control                          29.8t8.4                             &#226;&#8364;&#8220;                                             identified date, compound active low nM <br /> 6.25r107                                29.9t12.4                            &#226;&#8364;&#8220;                                             range, natural synthetic substances <br /> 1.25r107                                35.1t7.0                             3759.5                                        (such IPP prenyl pyrophosphates, alkyl- <br /> 2.5r106                                 40.4t1.4                             1823.8 <br />                                                                                                                            phosphates, alkylamines, aminobisphosphonates) have <br /> 5.0r105                                 52.2t0.2                             2592.5 <br /> 1.0r105                                 63.0t1.3                             3104.2 <br />                                                                                                                            bioactivities 1 100 mM.13,15,28,29,40&#226;&#8364;&#8220; 42 Only <br /> 2.0r104                                 66.2t0.6                             1065.9                                        now, synthetic FBPP derivatives halohydrin <br /> MeantSEM1                               &#226;&#8364;&#8220;                                    2469.2t472.7                                  pyrophosphates bioactivities similar to, above, <br />                                                                                                                            naturally occurring cd T-cell activator, been <br />    *A calibration curve obtained using serial dilutions                                                          described.43&#226;&#8364;&#8220; 46 However, connection FBPP and <br /> isopentenyl pyrophosphate (IPP) standard, ranging 80 nM <br />                                                                                                                            MEP pathway isoprenoid synthesis been <br /> to 10 mM yielding formula (at R2=0.99): Bioactivity <br />                           . <br /> (mM IPP)=0.000869re0 167r(CD69 expression level).                                                                          deduced indirectly close structural similarity <br />    {Upregulation CD69 expression monitored incubation                                                         FBPP IPP.17 A mass 262 atomic units as <br /> of peripheral blood mononuclear cells 18 hr presence serial                                                  fragments m/z 243 m/z 159, our <br /> dilutions fraction DlytB #20 (n=3). <br />                                                                                                                            present study, accordance chemical structure <br />    {Bioactivity fraction DlytB #20 calculated dilution <br /> using formula: BioactivityDlytB #20 (mM IPP)=(1/1000r[bioactivity                                                      FBPP;17 however, related molecules 3,4-epoxy- <br /> (mM IPP)rdilution factor]).                                                                                                3-methyl-1-butyl pyrophosphate (EpoxPP), give <br />    1Mean bioactivity dilutions tested resulted                                                       identical fragmentation patterns,44 making the <br /> upregulation CD69 expression background value. An <br />                                                                                                                            MS-based approach insufficient support proposed <br /> analogous experiment measuring cd T-cell expansion 6 days <br /> resulted bioactivity value 2487.6t911.4 mM IPP.                                                                    structure.45 Indeed, recent 1H, 13C 31P NMR spectros- <br />    SEM, standard error mean.                                                                                        copy studies purified substance identified the <br />                                                                  277.0 <br />  <br />  <br />  <br />  <br />                           DgcpE <br />  <br />                                         100 <br />                           % Intensity <br />  <br />  <br />  <br />  <br />                                          50 <br />                                                   216.9 <br />  <br />                                                                      299.0 <br />  <br />  <br />                                                                               396.9 <br />                                                  133.0 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                      1192.2 <br />                                                                                                                   554.9 <br />                                                 179.0 <br />                                                  97.0 <br />  <br />  <br />  <br />                                                 244.1 <br />  <br />  <br />                                                                              374.9 <br />  <br />  <br />  <br />  <br />                                                                                                                                           771.2 <br />                                                                                                                                   673.2 <br />  <br />  <br />  <br />  <br />                                                                                                                                                       854.9 <br />  <br />  <br />  <br />  <br />                                             0 <br />                                                                   300                                   550                                800                1050            m/z <br />                                                                 [M-H]&#226;&#8364;&#8220; <br />                                                                 261.0 <br />  <br />  <br />  <br />  <br />                           DlytB <br />  <br />                                         100 <br />                                                                               380.9 [M+NaHPO4]&#226;&#8364;&#8220; <br />                           % Intensity <br />  <br />  <br />  <br />  <br />                                                                                                   523.0 [2M-H]&#226;&#8364;&#8220; <br />  <br />  <br />  <br />  <br />                                          50 <br />                                                                  277.0 <br />                                                         216.9 <br />                                                        158.9 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                      1192.2 <br />                                                 97.0 <br />  <br />  <br />  <br />  <br />                                                                                                                                               806.9 <br />                                                                                                                           642.9 <br />  <br />  <br />  <br />  <br />                                             0 <br />                                                                   300                                   550                                800                1050            m/z <br />  <br />         Figure 6. Negative mode electrospray ionization-mass spectrometry (ESI-MS) analysis fractions DgcpE #20 DlytB #20. <br />  <br />  <br /> #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />  208                                                                        M. Eberl et al. <br />  <br />  <br />  <br />  <br />       CD69+ (% Vc9+ CD3+ lymphocytes) <br />                                         100                              100                                100 <br />  <br />                                          80                               80                                 80 <br />  <br />                                          60                               60                                 60 <br />  <br />                                          40                               40                                 40 <br />  <br />                                          20                               20                                 20 <br />  <br />                                           0                                0                                  0 <br />                                                0   0.1     1.0    10.0          0   0.1    1.0       10.0          0   0.1    1.0   10.0 <br />       CD25+ (% Vc9+ CD3+ lymphocytes) <br />  <br />  <br />  <br />  <br />                                         100                              100                                100 <br />  <br />                                          80                               80                                 80 <br />  <br />                                          60                               60                                 60 <br />  <br />                                          40                               40                                 40 <br />  <br />                                          20                               20                                 20 <br />  <br />                                           0                                0                                  0 <br />                                                0   0.1     1.0    10.0          0   0.1    1.0       10.0          0   0.1    1.0   10.0 <br />  <br />  <br />                                          30                               30                                 30 <br />       Vc9+ (% CD3+ lymphocytes) <br />  <br />  <br />  <br />  <br />                                          20                               20                                 20 <br />  <br />  <br />  <br />                                          10                               10                                 10 <br />  <br />  <br />  <br />                                           0                                0                                  0 <br />                                                0   0.1     1.0    10.0          0   0.1    1.0       10.0          0   0.1    1.0   10.0 <br />  <br />  <br />                                         800                              800                                 800 <br />  <br />  <br />                                         600                              600                                 600 <br />             TNF-a (pg/ml) <br />  <br />  <br />  <br />  <br />                                         400                              400                                 400 <br />  <br />  <br />                                         200                              200                                 200 <br />  <br />  <br />                                           0                                0                                  0 <br />                                                0   0.1     1.0    10.0          0   0.1    1.0       10.0          0   0.1    1.0   10.0 <br />  <br />  <br />                                         2500                             2500                               2500 <br />  <br />                                         2000                             2000                               2000 <br />             IFN-c (pg/ml) <br />  <br />  <br />  <br />  <br />                                         1500                             1500                               1500 <br />  <br />                                         1000                             1000                               1000 <br />  <br />                                          500                              500                                500 <br />  <br />                                           0                                0                                  0 <br />                                                0    0.1    1.0    10.0          0    0.1     1.0 10.0              0    0.1     1.0 10.0 <br />                                                    IL-2 (ng/ml)                     IL-15 (ng/ml)                      IL-21 (ng/ml) <br />  <br />  <br />  <br />  <br />                                                                                                  #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />                                            A potent cd T-cell activator DlytB E. coli                                                  209 <br />  <br />  <br /> cd TCR ligand accumulating E. coli DlytB mutants                       eluted anion-exchange column same <br /> as HMB-PP, novel compound derived MEP                          conditions m/z 261 compound; correspon- <br /> pathway &lt;104 times potent activating Vc9/                 dence chromatographical behaviour result <br /> Vd2 T cells IPP.30 In contrast FBPP, chemical                 close chemical similarity metabolites <br /> structure HMB-PP accordance incorporation                   MEP pathway. The presence pyrophosphate <br /> studies using deuterium-labelled ME isotopomers,18                    group m/z 277 molecule confirmed ion trap <br /> insinuates elegant mechanism unclear                 MS/MS (U. Bahr M. Hintz, unpublished). These find- <br /> biosynthetic reaction sequence leading MEcPP IPP                  ings suggest E. coli DgcpE overproduc- <br /> (Fig. 8). However, present know                  tion MEcPP serve putative substrate <br /> Vc9/Vd2 TCR ligand actual substrate LytB                    GcpE enzyme catalysing synthesis natural <br /> merely represents product MEP pathway,                      cd TCR ligand, precursor.47 This conclusion cor- <br /> utilizing intermediate produced GcpE (or                    roborated recent data indicating MEcPP itself does <br /> yet-unidentified enzyme downstream GcpE). Yet,                         display cd T-cell activity.48 <br /> recently Hecht et al. detected HMB-PP bacteria                        In addition molecular characterization the <br /> overexpressing gcpE gene,47 supporting                   cd T-cell activator, identified IL-21 potent <br /> conclusions.30                                                            costimulator human phosphoantigen-reactive Vc9/Vd2 <br />     Finally, important note E. coli DgcpE                   T cells. This confirms expansion activated cd T cells <br /> mutants accumulate metabolite derived                     depends additional growth factors derive <br /> from MEP pathway, detectable mass m/z 277                     bystander CD4+ T cells antigen-specific <br />                                                                           immune response pathogen, IL-2, IL-4 or <br />                                                                           IL-7, cells innate immune early <br />                                 DOXP <br />                                                                           stages infection CD4+ T cells been <br />                                                                           recruited, like IL-12 IL-15.26 The synergism between <br />                                         Dxr                               IL-21 IL-2 IL-15 accordance previous <br />                                                                           findings showing combinations IL-21 IL-2 <br />                                  MEP                                      IL-15 additive effect lytic function of <br />                                         YgbP                              human natural killer cells; also, IL-21 potentiates <br />                                         YchB                              costimulation murine T-cell proliferation IL-2 <br />                                         YgbB                              IL-15.25,49 The biological implication seemingly <br />                                                                           redundant utilization IL-21 Vc9/Vd2 T-cell <br />                                 MEcPP <br />                                                                           costimulator remains elucidated, IL-2 and <br />                                         GcpE                              IL-21 produced activated CD4+ T cells, and <br />                                                                           signalling interleukins, IL-2, IL-15 IL-21, <br />                                HMB-PP <br />                                                                           respective receptors involves activation STAT1, <br />                           (cd T cell activator)                           STAT3 STAT5, JAK1 JAK3.50,51 In <br />                                                                           respect, intriguing IL-21 similar effects as <br />                                         LytB                              IL-2 IL-15 DlytB #20-driven cd T-cell pro- <br />                                                                           liferation CD25 CD69 surface expression, is <br />                                   IPP                                     far active stimulating DlytB #20-induced <br />                                                                           secretion IFN-c TNF-a PBMC. These findings <br /> Figure 8. Proposed scheme final biosynthetic reactions <br />                                                                           demonstrate production proinflammatory <br /> of 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway in <br /> Escherichia coli. Initially, 1-deoxy-D-xylulose 5-phosphate (DOXP)        cytokines, considered key function of <br /> is converted MEP DOXP reductoisomerase (Dxr).                     Vc9/Vd2 T cells widely used read-out bio- <br /> Subsequently, enzymes YgbP, YchB YgbB catalyse                activity assays,27,38,39 necessarily associated with <br /> transformation MEP 2-C-methyl-D-erythritol 2,4-cyclo-             proliferating Vc9/Vd2 T cells. The immunology IL-21 <br /> pyrophosphate (MEcPP), molecular mass (Mr) 278.                 costimulated phosphoantigen-reactive Vc9/Vd2 T cells is <br /> GcpE involved step(s) using MEcPP substrate          worth attention. <br /> produce cd T-cell activator, (E )-4-hydroxy-3-methyl-but-2-enyl           Taken together, demonstrated pyrophos- <br /> pyrophosphate (HMB-PP) Mr 262, LytB mediates <br />                                                                           phorylated molecule Mr 262 accounts strong <br /> a/the subsequent reaction leading IPP. <br />                                                                           immunogenicity mutant E. coli strain deficient lytB. <br />  <br />  <br />         Figure 7. Dependence cd T-cell activity costimulation interleukin (IL)-2, IL-15 IL-21. Peripheral blood <br />         mononuclear cells incubated medium (open circles), DlytB #20 dilution 1 100 000, <br />         corresponding bioactivity equivalent 25 mM isopentenyl pyrophosphate (IPP) (solid circles), presence different <br />         concentrations recombinant cytokines. Data shown represent mean value+SEM expression CD69 CD25 <br />         Vc9+ CD3+ T cells, outgrowth Vc9+ T cells CD3+ T cells, secretion interferon-c (IFN-c) and <br />         tumour necrosis factor-a (TNF-a) (all n=6 n=3 IFN-c). *P&lt;0.05 compared corresponding medium <br />         controls, using two-tailed Student&#226;&#8364;&#8482;s t-test paired data. <br />  <br />  <br /> #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />  210                                                          M. Eberl et al. <br />  <br />  <br /> As increasing evidence Vc9/Vd2 T cells                    11 Eisenreich W, Rohdich F, Bacher A. Deoxyxylulose phosphate <br /> contribute immune response                      pathway terpenoids. Trends Plant Sci 2001; 6:78&#226;&#8364;&#8220;84. <br /> most harmful pathogens infecting humans, unexpected                 12 Sicard H, Fournie&#194;&#180; JJ. Metabolic routes targets for <br /> accessibility natural Vc9/Vd2 TCR ligand large                   immunological discrimination host parasite. Infect <br />                                                                            Immun 2000; 68:4375&#226;&#8364;&#8220;7. <br /> quantities, identification IL-21 potent growth <br />                                                                         13 Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, <br /> factor, aid understanding unconven- <br />                                                                            Bonneville M, Fournie&#194;&#180; JJ. Stimulation human cd T cells by <br /> tional function Vc9/Vd2 T cells diseases                     nonpeptidic mycobacterial ligands. Science 1994; 264:267&#226;&#8364;&#8220;70. <br /> tuberculosis, tularemia, malaria, Crohn&#226;&#8364;&#8482;s disease.52&#226;&#8364;&#8220;55              14 Tanaka Y, Sano S, Nieves E et al. Nonpeptide ligands for <br /> The fact presence IL-21, DlytB #20-reactive                 human cd T cells. Proc Natl Acad Sci USA 1994; 91:8175&#226;&#8364;&#8220;9. <br /> Vc9/Vd2 T-cells proliferate secreting significant               15 Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, <br /> levels proinflammatory cytokines consider-                    Bloom BR. Natural synthetic non-peptide antigens <br /> able relevance immunotherapeutic approaches                   recognized human cd T cells. Nature 1995; 375:155&#226;&#8364;&#8220;8. <br /> infections.                                                             16 Poquet Y, Constant P, Halary F et al. A novel nucleotide- <br />                                                                            containing antigen human blood cd T lymphocytes. Eur <br />                                                                            J Immunol 1996; 26:2344 &#226;&#8364;&#8220;9. <br />                    ACKNOWLEDGMENTS                                      17 Belmant C, Espinosa E, Poupot R, Peyrat MA, Guiraud M, <br /> This study supported Bundesministerium fu&#194;&#168;r Bildung             Poquet Y, Bonneville M, Fournie&#194;&#180; JJ. 3-Formyl-1-butyl <br /> und Forschung (BioChance 0312588), studentship               pyrophosphate: novel mycobacterial metabolite-activating <br /> the Deutsche Forschungsgemeinschaft (to A.K.K). We gratefully              human cd T cells. J Biol Chem 1999; 274:32079&#226;&#8364;&#8220;84. <br /> acknowledge Rosel Engel, Christian Haug, Dajana Henschker,              18 Charon L, Hoeffler JF, Pale-Grosdemange C, Lois LM, <br /> Ursula Jost, Irina Steinbrecher, Stefanie Wagner excellent         Campos N, Boronat A, Rohmer M. Deuterium-labelled <br /> technical assistance; Erhard Dreiseidler, Claus Weidemeyer,            isotopomers 2-C-methyl-D-erythritol tools elucida- <br /> and Oliver Wolf helpful discussions.                                   tion 2-C-methyl-D-erythritol 4-phosphate pathway for <br />                                                                            isoprenoid biosynthesis. Biochem J 2000; 346:737&#226;&#8364;&#8220; 42. <br />                                                                         19 Takahashi S, Kuzuyama T, Watanabe H, Seto H. An 1-deoxy- <br />                          REFERENCES                                        D-xylulose 5-phosphate reductoisomerase catalyzing forma- <br />                                                                            tion 2-C-methyl-D-erythritol 4-phosphate alternative <br />  1 Goerlich R, Hacker G, Pfeffer K, Heeg K, Wagner H. <br />                                                                            nonmevalonate pathway terpenoid biosynthesis. Proc Natl <br />    Plasmodium falciparum merozoites primarily stimulate the <br />                                                                            Acad Sci USA 1998; 95:9879&#226;&#8364;&#8220;84. <br />    Vc9 subset human c/d T cells. Eur J Immunol 1991; <br />                                                                         20 Altincicek B, Kollas AK, Sanderbrand S, Wiesner J, Hintz M, <br />    21:2613&#226;&#8364;&#8220;6. <br />                                                                            Beck E, Jomaa H. GcpE involved 2-C-methyl-D- <br />  2 Kabelitz D, Bender A, Schondelmaier S, Schoel B, <br />                                                                            erythritol 4-phosphate pathway isoprenoid biosynthesis in <br />    Kaufmann SH. A large fraction human peripheral blood <br />                                                                            Escherichia coli. J Bacteriol 2001; 183:2411&#226;&#8364;&#8220;6. <br />    c/d+ T cells activated Mycobacterium tuberculosis not <br />                                                                         21 Altincicek B, Kollas AK, Eberl M, Wiesner J, Sanderbrand S, <br />    65-kDa heat shock protein. J Exp Med 1990; 171:667&#226;&#8364;&#8220;75. <br />                                                                            Hintz M, Beck E, Jomaa H. LytB, novel gene 2-C- <br />  3 Jomaa H, Feurle J, Luhs K, Kunzmann V, Tony HP, <br />    Herderich M, Wilhelm M. Vc9/Vd2 T cell activation induced               methyl-D-erythritol 4-phosphate pathway isoprenoid <br />    bacterial low molecular mass compounds depends                    biosynthesis Escherichia coli. FEBS Lett 2001; 499:37&#226;&#8364;&#8220; 40. <br />    1-deoxy-D-xylulose 5-phosphate pathway isoprenoid             22 Cunningham FX Jr, Lafond TP, Gantt E. Evidence role for <br />    biosynthesis. FEMS Immunol Med Microbiol 1999; 25:371&#226;&#8364;&#8220;8.                LytB nonmevalonate pathway isoprenoid biosynthesis. <br />  4 Altincicek B, Moll J, Campos N et al. Human cd T cells              J Bacteriol 2000; 182:5841&#226;&#8364;&#8220;8. <br />    activated intermediates 2-C-methyl-D-erythritol            23 Campos N, Rodr&#196;&#177;&#194;&#180;guez-Concepcio&#194;&#180;n M, Seemann M, Rohmer M, <br />    4-phosphate pathway isoprenoid biosynthesis. J Immunol               Boronat A. Identification gcpE novel gene 2-C- <br />    2001; 166:3655&#226;&#8364;&#8220;8.                                                       methyl-D-erythritol 4-phosphate pathway isoprenoid bio- <br />  5 Rohmer M, Knani M, Simonin P, Sutter B, Sahm H. Isoprenoid              synthesis Escherichia coli. FEBS Lett 2001; 488:170 &#226;&#8364;&#8220;3. <br />    biosynthesis bacteria: novel pathway early              24 Altincicek B, Hintz M, Sanderbrand S, Wiesner J, Beck E, <br />    steps leading isopentenyl diphosphate. Biochem J 1993;               Jomaa H. Tools discovery inhibitors 1-deoxy-D- <br />    295:517&#226;&#8364;&#8220;24.                                                             xylulose 5-phosphate (DXP) synthase DXP reducto- <br />  6 Rosa Putra S, Disch A, Bravo JM, Rohmer M. Distribution              isomerase: approach enzymes pathogenic <br />    mevalonate glyceraldehyde 3-phosphate/pyruvate routes               bacterium Pseudomonas aeruginosa. FEMS Microbiol Lett <br />    isoprenoid biosynthesis Gram-negative bacteria          2000; 190:329&#226;&#8364;&#8220;33. <br />    mycobacteria. FEMS Microbiol Lett 1998; 164:169&#226;&#8364;&#8220;75.                  25 Parrish-Novak J, Dillon SR, Nelson A et al. Interleukin 21 and <br />  7 Jomaa H, Wiesner J, Sanderbrand S et al. Inhibitors                  receptor involved NK cell expansion regulation <br />    nonmevalonate pathway isoprenoid biosynthesis                 lymphocyte function. Nature 2001; 408:57&#226;&#8364;&#8220;63. <br />    antimalarial drugs. Science 1999; 285:1573&#226;&#8364;&#8220;6.                        26 Wesch D, Marx S, Kabelitz D. Comparative analysis ab <br />  8 Rohmer M. The discovery mevalonate-independent path-               cd T cell activation Mycobacterium tuberculosis and <br />    way isoprenoid synthesis bacteria, algae higher plants.      isopentenyl pyrophosphate. Eur J Immunol 1997; 27:952&#226;&#8364;&#8220;6. <br />    Nat Prod Rep 1999; 16:565&#226;&#8364;&#8220;74.                                        27 Garc&#196;&#177;&#194;&#180;a VE, Sieling PA, Gong J et al. Single-cell cytokine <br />  9 Lange BM, Rujan T, Martin W, Croteau R. Isoprenoid                      analysis cd T cell responses nonpeptide mycobacterial <br />    biosynthesis: evolution ancient distinct pathways        antigens. J Immunol 1997; 159:1328&#226;&#8364;&#8220;35. <br />    genomes. Proc Natl Acad Sci USA 2000; 97:13172&#226;&#8364;&#8220;7.             28 Bukowski JF, Morita CT, Brenner MB. Human cd T cells <br /> 10 Boucher Y, Doolittle WF. The role lateral gene transfer       recognize alkylamines derived microbes, edible plants, <br />    evolution isoprenoid biosynthesis pathways. Mol Microbiol            tea: implications innate immunity. Immunity 1999; <br />    2000; 37:703&#226;&#8364;&#8220;16.                                                        11:57&#226;&#8364;&#8220;65. <br />  <br />  <br />                                                                                 #   2002 Blackwell Science Ltd, Immunology, 106, 200&#226;&#8364;&#8220;211 <br />                                       A potent cd T-cell activator DlytB E. coli                                                 211 <br />  <br /> 29 Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP,              42 Espinosa E, Belmant C, Sicard H, Poupot R, Bonneville M, <br />    Wilhelm M. Stimulation cd T cells aminobisphosphonates          Fournie&#194;&#180; JJ. Y2K+1 state-of-the-art non-peptide phospho- <br />    induction antiplasma cell activity multiple myeloma.        antigens, novel category immunostimulatory molecules. <br />    Blood 2000; 96:384 &#226;&#8364;&#8220;92.                                               Microbes Infect 2001; 3:645&#226;&#8364;&#8220;54. <br /> 30 Hintz M, Reichenberg A, Altincicek B et al. Identification      43 Belmant C, Espinosa E, Halary F et al. A chemical basis for <br />    (E )-4-hydroxy-3-methyl-but-2-enyl pyrophosphate major           selective recognition nonpeptide antigens human cd T cells. <br />    activator human cd T cells Escherichia coli. FEBS Lett         FASEB J 2000; 14:1669&#226;&#8364;&#8220;70. <br />    2001; 509:317&#226;&#8364;&#8220;22.                                                  44 Pont F, Luciani B, Belmant C, Fournie&#194;&#180; JJ. Characterization <br /> 31 Kaufmann SH. c/d unconventional T lymphocytes:              phosphoantigens high-performance anion-exchange <br />    what do? Proc Natl Acad Sci USA          chromatography-electrospray ionization ion trap mass <br />    1996; 93:2272&#226;&#8364;&#8220;9.                                                      spectrometry nanoelectrospray ionization ion trap mass <br /> 32 Kabelitz D, Glatzel A, Wesch D. Antigen recognition                spectrometry. Anal Chem 2001; 73:3562&#226;&#8364;&#8220;9. <br />    human cd T lymphocytes. Int Arch Allergy Immunol 2000;             45 Feurle J, Espinosa E, Eckstein S et al. E. coli produces <br />    122:1&#226;&#8364;&#8220;7.                                                              phosphoantigens activating human cd T cells. J Biol Chem 2002; <br /> 33 Munk ME, Gatrill AJ, Kaufmann SH. Target cell lysis IL-2          277:148&#226;&#8364;&#8220;54. <br />    secretion c/d T lymphocytes activation bacteria.     46 Espinosa E, Belmant C, Pont F et al. Chemical synthesis <br />    J Immunol 1990; 145:2434 &#226;&#8364;&#8220;9.                                          biological activity bromohydrin pyrophosphate, a <br /> 34 Morita CT, Li H, Lamphear JG, Rich RR, Fraser JD,                     potent stimulator human cd T cells. J Biol Chem 2001; <br />    Mariuzza RA, Lee HK. Superantigen recognition cd <br />                                                                          276:18337&#226;&#8364;&#8220; 44. <br />    T cells: SEA recognition site human Vc2 T cell receptors. <br />                                                                       47 Hecht S, Eisenreich W, Adam P et al. Studies the <br />    Immunity 2001; 14:331&#226;&#8364;&#8220; 44. <br />                                                                          nonmevalonate pathway terpenes: role GcpE <br /> 35 Allison TJ, Winter CC, Fournie&#194;&#180; JJ, Bonneville M, Garboczi DN. <br />                                                                          (IspG) protein. Proc Natl Acad Sci USA 2001; 98:14837&#226;&#8364;&#8220; 42. <br />    Structure human cd T-cell antigen receptor. Nature 2001; <br />                                                                       48 Potapov VD, Biketov SF, Demina GR, Lysak EI, Titareva GM, <br />    411:820 &#226;&#8364;&#8220; 4. <br />                                                                          Bakhteeva IV, Ostrovsky DN. Immunomodulatory properties <br /> 36 Borsellino G, Poccia F, Placido R et al. Phenotypic and <br />                                                                          2-C-methyl-D-erythritol 2,4-cyclopyrophosphate the <br />    functional properties cd T cells patients Guillain <br />                                                                          search new derivatives. Appl Biochem Microbiol 2001; <br />    Barre&#194;&#180; syndrome. J Neuroimmunol 2000; 102:199&#226;&#8364;&#8220;207. <br /> 37 Boullier S, Poquet Y, Halary F, Bonneville M, Fournie JJ,             37:238&#226;&#8364;&#8220; 41. <br />    Gougeon ML. Phosphoantigen activation induces surface              49 Vo&#195;&#376;henrich CA, di Santo JP. Cytokines: IL-21 joins the <br />    translocation intracellular CD94/NKG2A class I receptor            cc-dependent network? Curr Biol 2001; 11:R175&#226;&#8364;&#8220;7. <br />    CD94x peripheral Vc9Vd2 T cells CD94x thymic         50 Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. <br />    mature cd T cell clones. Eur J Immunol 1998; 28:3399&#226;&#8364;&#8220; 410.         Cloning type I cytokine receptor related IL-2 <br /> 38 Sireci G, Champagne E, Fournie&#194;&#180; JJ, Dieli F, Salerno A. Patterns      receptor beta chain. Proc Natl Acad Sci USA 2000; <br />    phosphoantigen stimulation human Vc9/Vd2 T cell clones          97:11439&#226;&#8364;&#8220; 44. <br />    include Th0 cytokines. Hum Immunol 1997; 58:70 &#226;&#8364;&#8220;82.                51 Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D, <br /> 39 Lafont V, Liautard J, Liautard JP, Favero J. Production            Sugamura K. Th <br /> </body></html>